| (CHF) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 391.95M | 15.70% |
| Operating expense | — | — |
| Net income | -21.17M | 8.20% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PPGN.SW returned +55.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +68.4% |
| 1 year | +55.9% |
| 5 years | -66.8% |
| All-time high | CHF 137.00 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what CHF1,000 in PPGN.SW would be worth today ›No. PolyPeptide Group AG has not paid a dividend in the past 12 months.
PolyPeptide Group AG is part of the Healthcare sector.
PolyPeptide Group AG has a market cap of 1.45B CHF, based on the latest quote.
